US Stock MarketDetailed Quotes

ACLX Arcellx

Watchlist
  • 51.920
  • +0.540+1.05%
Close Apr 26 16:00 ET
  • 51.920
  • 0.0000.00%
Post 16:20 ET
2.77BMarket Cap-35319P/E (TTM)

About Arcellx Company

Arcellx, Inc is a clinical-stage biotechnology company, which provides cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases. The company was founded by David M. Hilbert and Luba Zaritskaya in December 2014 and is headquartered in Gaithersburg, MD.

Company Profile

SymbolACLX
Company NameArcellx
Listing DateFeb 4, 2022
Issue Price15.00
Founded2014
CEOMr. Rami Elghandour
MarketNASDAQ
Employees130
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address25 West Watkins Mill Road,Suite A
CityGaithersburg
ProvinceMaryland
CountryUnited States of America
Zip Code20878
Phone1-240-327-0603
Websitehttp://www.arcellx.com

Company Executives

  • Name
  • Position
  • Salary
  • Rami Elghandour
  • President, Chief Executive Officer and Chairman of the Board
  • 24.96M
  • Dr. Christopher Heery, M.D.
  • Chief Medical Officer
  • 3.86M
  • Michelle Gilson
  • Chief Financial Officer and Principal Accounting Officer
  • 3.55M
  • Olivia C. Ware, M.B.A.
  • Independent Director
  • 343.67K
  • Jill Carroll, M.S.
  • Independent Director
  • 353.67K
  • Dr. Kavita K. Patel, M.D.
  • Independent Director
  • 344.67K
  • Derek Yoon
  • Independent Director
  • 347.17K
  • Dr. Ali Behbahani, M.B.A.,M.D.
  • Independent Director
  • 355.17K
  • David Charles Lubner, C.P.A.,M.S.
  • Independent Director
  • 359.67K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg